Doron is the founder and CEO of Affera, Inc. Prior to Affera, Doron co-founded and served as co-CEO at Rhythmia Medical, which developed a unique Electroanatomical Mapping System for the treatment of Cardiac Arrhythmia. Acquired by Boston Scientific in 2012, Rhythmia became Boston Scientific’s cardiac mapping and navigation division, where Doron served as Vice President of Product and Technology. Prior to Rhythmia, Doron held a variety of roles in an elite R&D unit in the Israeli Ministry of Defense.
Doron is a prolific inventor holding over 130 issued and pending patents. He is currently an advisor to a number of start-up companies, and serves as a Board member at Lexington Medical, Inc. Doron holds an MBA from MIT Sloan, M.Sc. EE from Tel Aviv University and B.Sc. EE from the Technion Israel Institute of Technology.